Home Insights Global vaccine forecasting

Global vaccine forecasting

Less than 1 min read
The challenge:

A competitor vaccine manufacturer recently put a temporary hold on their vaccine development program, requiring Putnam’s client to update their global commercial forecast to account for a range of potential competitive launch scenarios. The forecast would be used to inform commercial strategy and supply chain decisions.

Our solution:

Research objectives:

  • Assess likelihood to recommend, stock vaccine across patient types and scenarios
  • Quantify willingness to accept the vaccine based on variations in out-of-pocket cost and HCP recommendation
  • Understand likelihood of protocol inclusion (LTC) and stocking likelihood (LTC + pharmacy)

Our approach:
We conducted four key research studies in US, EU5, and Japan:

  1. HCP Quantitative Demand Study
  2. Patient Quantitative Willingness to Pay Study
  3. Pharmacy Stakeholder Interviews
  4. Long-term Care Stakeholder Interviews

Both quantitative studies used a monadic design approach to test the impact of several competitive scenarios.

The results:

Putnam delivered the findings and forecast inputs through a series of workshops with various client teams. This built alignment around the updated competitive landscape and helped team confidently make changes to their strategy.